In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Person-centred telephone-support is effective in patients with chronic obstructive pulmonary disease and/or chronic heart failure - six-month follow-up of a randomized controlled trial

Session Nursing Investigator Award

Speaker Lilas Ali

Congress : Heart Failure 2018

  • Topic : cardiovascular nursing and allied professions
  • Sub-topic : Cardiovascular Nursing and Allied Professions - Other
  • Session type : Young Investigator Award Abstracts
  • FP Number : 781

Authors : A Fors (Gothenburg,SE), E Blanck (Gothenburg,SE), L Ali (Gothenburg,SE), K Swedberg (Gothenburg,SE), I Ekman (Gothenburg,SE)

Authors:
A Fors1 , E Blanck1 , L Ali1 , K Swedberg2 , I Ekman1 , 1University of Gothenburg, Sahlgrenska Academy, Centre for Person-Centred Care (GPCC), Institute of Health and Care Sciences - Gothenburg - Sweden , 2University of Gothenburg, Sahlgrenska Academy, Centre for Person-Centred Care (GPCC), Department of Molecular and Clinical Medicine - Gothenburg - Sweden ,

Citation:

Background
Long term health conditions, including chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD), are one of the major challenges facing healthcare systems worldwide; and telehealth has been suggested as a safe option to promote self-management. The effectiveness of person-centred care as a tool to improve health care has been demonstrated in several conditions and contexts but there are few existing telehealth interventions that fully address person-centred care. 

Purpose
To evaluate the effects of person-centred support at distance via telephone for patients with CHF and/or COPD.

Method
221 patients = 50 years with CHF and/or COPD were randomized to usual care or a person-centred telephone-support intervention in addition to usual care and followed during six months. In the intervention group patients where phone called by a registered nurse and a person-centred health plan reflecting both perspectives was co-created, which was further discussed and evaluated during additional follow-ups by telephone. A composite score of changes that included changes in general self-efficacy = 5 units, re-hospitalization and death was used as primary outcome measure.

Results At the six-month follow-up no difference in the composite score was found between the two study groups (57.6%, n = 68 vs. 46.6%, n = 48; OR = 1.6, 95 % CI: 0.9 – 2.7; P = 0.102). Significantly more patients in the control group decreased = 5 units in general self-efficacy (22.9%, n=27 vs. 9.7%, n=10; OR = 2.8, 95% CI: 1.3 – 6.0; P = 0.011). There were no differences between groups on re-hospitalization or death. In the per-protocol analysis of the composite score more patients in the control group deteriorated compared with the intervention group (57.6%, n = 68 vs. 42.9%, n = 36; OR = 1.8, 95% CI 1.0 – 3.2; P = 0.039).

Conclusion
A person-centred support at distance via telephone mitigates worsened self-efficacy without increasing the risk of clinical events in patients with CHF and/or COPD. This highlights the possibility to establish a patient-health care professional partnership, which is not dependent on face-to-face consultations, not the least in vulnerable patient groups.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are